Augmedix Announces Participation in Maxim Group Healthcare IT Investor Conference on January 25
SAN FRANCISCO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (NASDAQ:AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced that its
Augmedix Backs 4Q Rev $8.5M-$8.6M >AUGX
Augmedix Expects to Take a 4Q Non-Cash Chg of $215,000 Related to the Cancellation of Its At-The-Market Program >AUGX
Press Release: Augmedix Exits Calendar 2022 With Expected $35 Million in Annual Recurring Revenue
Augmedix Exits Calendar 2022 with Expected $35 Million in Annual Recurring Revenue Company Also Expects Fourth Quarter Revenue to be Within the Guidance Range SAN FRANCISCO, Jan. 09, 2023 (GLOBE NEW
Augmedix (OTCMKTS:AUGX) Earns "Buy" Rating From B. Riley
B. Riley reiterated their buy rating on shares of Augmedix (OTCMKTS:AUGX – Get Rating) in a report released on Thursday morning, PriceTargets.com reports. Augmedix Stock Performance OTCMKTS:AUGX ope
B. Riley Resumes Augmedix at Buy With $4 Price Target
Augmedix, Inc. (NASDAQ:AUGX) Q3 2022 Earnings Call Transcript
On December 20, 2022, Augmedix Delivered Written Notice To Jefferies To Terminate Sales Agreement; Company Is Not Subject To Any Termination Penalties Related To The Termination Of The Sales Agreement
On December 20, 2022, Augmedix Delivered Written Notice To Jefferies To Terminate Sales Agreement; Company Is Not Subject To Any Termination Penalties Related To The Termination Of The Sales Agreement
Analyzing Visa (NYSE:V) & Augmedix (OTCMKTS:AUGX)
Visa (NYSE:V – Get Rating) and Augmedix (OTCMKTS:AUGX – Get Rating) are both business services companies, but which is the better stock? We will contrast the two businesses based on the strength of t
Stocks That Hit 52-Week Lows On Tuesday
 On Tuesday, 49 companies hit new 52-week lows. Key Facts About Today's 52-Week Lows: Tesla (NASDAQ:TSLA) is the largest company in terms of market cap to set a new 52-week low this morning.The sma
Loading...
No Stock Yet